United Therapeutics (UTHR) Short Interest Ratio & Short Volume $338.22 +1.85 (+0.55%) (As of 07/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends United Therapeutics Short Interest DataCurrent Short Interest4,170,000 sharesPrevious Short Interest4,410,000 sharesChange Vs. Previous Month-5.44%Dollar Volume Sold Short$1.36 billionShort Interest Ratio7.4 Days to CoverLast Record DateJuly 15, 2024Outstanding Shares44,360,000 sharesFloat Size43,590,000 sharesShort Percent of Float9.57%Today's Trading Volume290,257 sharesAverage Trading Volume439,807 sharesToday's Volume Vs. Average66% Short Selling United Therapeutics ? Sign up to receive the latest short interest report for United Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartUTHR Short Interest Over TimeUTHR Days to Cover Over TimeUTHR Percentage of Float Shorted Over Time Ad The Oxford ClubMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new company could become the next to soar like Nvidia.Watch Alex's "Next Magnificent Seven" presentation now. United Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/20244,170,000 shares $1.36 billion -5.4%9.6%7.4 $327.26 6/30/20244,410,000 shares $1.40 billion +0.9%10.1%7.8 $318.55 6/15/20244,370,000 shares $1.26 billion +12.3%10.0%7.5 $288.06 5/31/20243,890,000 shares $1.07 billion +3.2%9.4%7.2 $275.13 5/15/20243,770,000 shares $1.03 billion -2.1%9.1%7.2 $272.69 4/30/20243,850,000 shares $902.17 million -10.9%9.4%7.4 $234.33 Get the Latest News and Ratings for UTHR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for United Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 4/15/20244,320,000 shares $1.02 billion -11.7%10.0%9.4 $235.08 3/31/20244,890,000 shares $1.12 billion +154.7%11.3%11.3 $229.72 3/15/20241,920,000 shares $452.70 million +64.1%4.4%4.7 $235.78 2/29/20241,170,000 shares $264.00 million +0.9%2.7%3 $225.64 2/15/20241,160,000 shares $248.87 million +11.5%2.7%3.3 $214.54 1/31/20241,040,000 shares $223.37 million -11.9%N/A3.3 $214.78 1/15/20241,180,000 shares $258.48 million +7.3%N/A3.6 $219.05 12/31/20231,100,000 shares $241.88 million -15.4%N/A3.5 $219.89 12/15/20231,300,000 shares $320.39 million +14.0%N/A4.2 $246.45 11/30/20231,140,000 shares $273.60 million +0.9%N/A4.2 $240.00 11/15/20231,130,000 shares $259.06 million +4.6%N/A4.4 $229.26 10/31/20231,080,000 shares $240.69 million +4.9%N/A3.6 $222.86 10/15/20231,030,000 shares $240.15 million +7.1%N/A3.4 $233.16 9/30/2023962,200 shares $217.33 million -13.3%N/A3.1 $225.87 9/15/20231,110,000 shares $244.47 million +1.8%N/A3.4 $220.24 8/31/20231,090,000 shares $244.55 million -42.3%N/A3.3 $224.36 8/15/20231,890,000 shares $445.53 million +94.6%N/A5.1 $235.73 7/31/2023971,100 shares $235.71 million -2.2%N/A2.7 $242.72 7/15/2023992,600 shares $230.28 million -8.1%N/A2.6 $232.00 6/30/20231,080,000 shares $238.41 million -5.3%N/A2.8 $220.75 6/15/20231,140,000 shares $261.73 million +9.6%N/A2.7 $229.59 5/31/20231,040,000 shares $218.13 million -22.4%N/A2.2 $209.74 5/15/20231,340,000 shares $287.30 million -8.2%N/A2.4 $214.40 4/30/20231,460,000 shares $335.99 million +6.6%N/A2.5 $230.13 4/15/20231,370,000 shares $313.35 million -3.5%N/A2.5 $228.72 3/31/20231,420,000 shares $318.02 million +6.0%N/A2.6 $223.96 3/15/20231,340,000 shares $291.45 million +0.8%N/A2.6 $217.50 2/28/20231,330,000 shares $327.23 million -5.0%N/A2.8 $246.04 2/15/20231,400,000 shares $354.70 million +11.1%3.1%3.6 $253.36 1/31/20231,260,000 shares $331.59 million -3.8%2.8%3.5 $263.17 1/15/20231,310,000 shares $341.96 million -1.5%2.9%3.4 $261.04 12/30/20221,330,000 shares $369.86 million +20.9%3.0%3.5 $278.09 12/15/20221,100,000 shares $303.44 million -17.9%2.5%3 $275.85 11/30/20221,340,000 shares $375.05 million -5.0%3.0%3.6 $279.89Get out of cash before the Fed's next meeting (Ad)"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all $20,000 of his wife's 401k into shares of just ONE stock. Everyone on Wall Street said he was crazy. But a year later, that $20,000 in his wife's account was worth $120,000. Today, he says: "If you thought the dot-com mania was intense, what's about to happen in the coming weeks could be even crazier and could open up a new window of opportunity for 500%-plus gains."Click here now to watch this exclusive interview 11/15/20221,410,000 shares $365.36 million +6.8%3.2%3.8 $259.12 10/31/20221,320,000 shares $304.30 million -7.0%3.0%3.5 $230.53 10/15/20221,420,000 shares $307.34 million +6.8%3.2%3.9 $216.44 9/30/20221,330,000 shares $278.48 million +7.3%3.0%3.5 $209.38 9/15/20221,240,000 shares $273.59 million +41.4%2.8%3.1 $220.64 8/31/2022877,000 shares $198.75 million -18.0%2.0%2 $226.62 8/15/20221,070,000 shares $233.65 million +1.9%2.4%2.2 $218.36 7/31/20221,050,000 shares $242.62 million -11.0%2.4%2.1 $231.07 7/15/20221,180,000 shares $283.29 million -3.3%2.7%2.4 $240.08 6/30/20221,220,000 shares $287.48 million -6.9%2.8%2.5 $235.64 6/15/20221,310,000 shares $288.32 million -16.0%3.0%2.6 $220.09 5/31/20221,560,000 shares $359.33 million -12.4%3.5%3.2 $230.34 5/15/20221,780,000 shares $326.52 million +58.9%4.0%3.6 $183.44 4/30/20221,120,000 shares $198.87 million +8.7%2.5%2.5 $177.56 4/15/20221,030,000 shares $197.67 million -38.3%2.3%2.3 $191.91 3/31/20221,670,000 shares $299.61 million +67.0%3.8%3.5 $179.41 3/15/20221,000,000 shares $178.82 million -32.0%2.3%2.3 $178.82 2/28/20221,470,000 shares $244.31 million -8.1%3.3%3.4 $166.20 2/15/20221,600,000 shares $326.86 million -9.6%3.6%3.8 $204.29 1/31/20221,770,000 shares $357.31 million +37.2%4.0%4.5 $201.87 1/15/20221,290,000 shares $276.01 million +19.4%2.9%3.1 $213.96 12/31/20211,080,000 shares $233.37 million -21.7%2.5%2.7 $216.08 12/15/20211,380,000 shares $269.96 million -22.0%3.1%3.4 $195.62 11/30/20211,770,000 shares $335.42 million -5.9%4.0%4.6 $189.50 11/15/20211,880,000 shares $385.46 million -21.3%4.3%5.1 $205.03 10/29/20212,390,000 shares $455.92 million +18.3%5.4%6.5 $190.76 10/15/20212,020,000 shares $377.88 million -14.4%4.5%5.5 $187.07 9/30/20212,360,000 shares $435.61 million -4.5%5.3%7 $184.58 9/15/20212,470,000 shares $504.55 million -23.8%5.6%7.6 $204.27 8/31/20213,240,000 shares $696.21 million +68.8%7.4%9.8 $214.88 8/13/20211,920,000 shares $389.03 million +18.5%4.4%5.4 $202.62 7/30/20211,620,000 shares $294.73 million -3.6%3.7%4.7 $181.93 7/15/20211,680,000 shares $309.44 million -4.6%3.8%5.5 $184.19 6/30/20211,760,000 shares $315.76 million No Change4.0%5.4 $179.41 6/15/20211,760,000 shares $314.07 million +0.6%4.0%4.6 $178.45 5/28/20211,750,000 shares $325.33 million -3.9%4.0%4.5 $185.90 5/14/20211,820,000 shares $352.66 million -9.9%4.2%4.8 $193.77 4/30/20212,020,000 shares $412.56 million No Change4.6%5.4 $204.24 4/15/20212,020,000 shares $409.62 million -13.7%4.7%5.5 $202.78 3/31/20212,340,000 shares $387.20 million +3.1%5.4%6 $165.47 3/15/20212,270,000 shares $362.07 million +18.2%5.2%6.7 $159.50 2/26/20211,920,000 shares $324.10 million +10.3%4.4%5.7 $168.80 2/12/20211,740,000 shares $294.98 million -1.1%4.0%5.4 $169.53 1/29/20211,760,000 shares $289.33 million +1.2%4.1%5.2 $164.39 1/15/20211,740,000 shares $291.03 million -7.9%4.0%4.4 $167.26 12/31/20201,890,000 shares $281.01 million -5.0%4.4%4.5 $148.68 12/15/20201,990,000 shares $284.85 million -3.9%4.6%4.9 $143.14 11/30/20202,070,000 shares $280.57 million -7.2%4.8%5.2 $135.54 10/30/20202,520,000 shares $328.23 million +12.5%5.8%6.8 $130.25 10/15/20202,240,000 shares $246.31 million +9.8%5.2%6.9 $109.96Get out of cash before the Fed's next meeting (Ad)"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all $20,000 of his wife's 401k into shares of just ONE stock. Everyone on Wall Street said he was crazy. But a year later, that $20,000 in his wife's account was worth $120,000. Today, he says: "If you thought the dot-com mania was intense, what's about to happen in the coming weeks could be even crazier and could open up a new window of opportunity for 500%-plus gains."Click here now to watch this exclusive interview 9/30/20202,040,000 shares $206.04 million +10.9%4.7%7 $101.00 9/15/20201,840,000 shares $194.58 million No Change4.3%5.4 $105.75 8/31/20201,840,000 shares $196.81 million +10.8%4.3%4.7 $106.96 8/14/20201,660,000 shares $181.72 million -0.6%3.8%3.7 $109.47 7/31/20201,670,000 shares $186.15 million -13.5%3.9%3.2 $111.47 7/15/20201,930,000 shares $228.45 million -17.2%4.6%3.2 $118.37 6/30/20202,330,000 shares $281.93 million -26.5%5.5%3.7 $121.00 6/15/20203,170,000 shares $365.88 million -1.9%7.5%4.9 $115.42 5/29/20203,230,000 shares $380.98 million +5.6%7.6%4.6 $117.95 5/15/20203,060,000 shares $356.06 million -14.0%7.2%4.2 $116.36 4/30/20203,560,000 shares $384.37 million +16.3%8.4%5.1 $107.97 4/15/20203,060,000 shares $298.07 million +7.4%7.2%4.6 $97.41 3/31/20202,850,000 shares $270.25 million -10.0%6.7%4.5 $94.83 3/13/20203,165,100 shares $303.44 million +37.6%7.5%4.6 $95.87 2/28/20202,300,000 shares $193.09 million +8.0%5.4%4.6 $83.95 2/14/20202,130,000 shares $214.04 million -10.5%5.0%4.7 $100.49 1/31/20202,380,000 shares $251.83 million +12.3%5.6%5.8 $105.81 1/15/20202,120,000 shares $214.44 million -2.8%5.0%5.1 $101.15 12/31/20192,180,000 shares $194.74 million +0.5%5.2%5.4 $89.33 UTHR Short Interest - Frequently Asked Questions What is United Therapeutics' current short interest? Short interest is the volume of United Therapeutics shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 4,170,000 shares of UTHR short. 9.57% of United Therapeutics' shares are currently sold short. Learn More on United Therapeutics' current short interest. What is a good short interest ratio for United Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. UTHR shares currently have a short interest ratio of 7.0. Learn More on United Therapeutics's short interest ratio. Which institutional investors are shorting United Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of United Therapeutics: Concourse Financial Group Securities Inc., Walleye Trading LLC, Jane Street Group LLC, Twin Tree Management LP, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for United Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.57% of United Therapeutics' floating shares are currently sold short. Is United Therapeutics' short interest increasing or decreasing? United Therapeutics saw a drop in short interest in the month of July. As of July 15th, there was short interest totaling 4,170,000 shares, a drop of 5.4% from the previous total of 4,410,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is United Therapeutics' float size? United Therapeutics currently has issued a total of 44,360,000 shares. Some of United Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. United Therapeutics currently has a public float of 43,590,000 shares. How does United Therapeutics' short interest compare to its competitors? 9.57% of United Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to United Therapeutics: Teva Pharmaceutical Industries Limited (1.56%), Blueprint Medicines Co. (7.65%), BridgeBio Pharma, Inc. (14.95%), Perrigo Company plc (4.36%), Arrowhead Pharmaceuticals, Inc. (7.28%), Biohaven Ltd. (11.11%), Bausch Health Companies Inc. (5.11%), Biogen Inc. (2.51%), Alnylam Pharmaceuticals, Inc. (3.55%), BioMarin Pharmaceutical Inc. (3.93%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks. What does it mean to sell short United Therapeutics stock? Short selling UTHR is an investing strategy that aims to generate trading profit from United Therapeutics as its price is falling. UTHR shares are trading up $1.85 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against United Therapeutics? A short squeeze for United Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of UTHR, which in turn drives the price of the stock up even further. How often is United Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including UTHR, twice per month. The most recent reporting period available is July, 15 2024. More Short Interest Resources from MarketBeat Related Companies: TEVA Short Squeeze BPMC Short Squeeze BBIO Short Squeeze PRGO Short Squeeze ARWR Short Squeeze BHVN Short Squeeze BHC Short Squeeze BIIB Short Squeeze ALNY Short Squeeze BMRN Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:UTHR) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThe asset beating inflation by 4xCentral Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire invest...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding United Therapeutics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share United Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free UTHR Stock Alerts